Normal adult height among girls treated for central precocious puberty with gonadotropin-releasing hormone analog therapy.

Abstract

AIM To evaluate adult height (AH) among girls with central precocious puberty (CPP) treated with gonadotropin releasing hormone analog (GnRHa) and to assess the impact of posttreatment growth on AH. STUDY DESIGN Medical records of girls with CPP were reviewed. RESULTS Twenty-six girls aged 7.2 +/- 2.0 years were identified. There was a significant… (More)

Topics

  • Presentations referencing similar topics